FDA Distinguished Alumni Award Recipients

2010

Joe Levitt - For exceptional leadership and advocacy of FDA through education and information thereby promoting greater understanding and support of the agency's mission to protect the public health (recipient nominated by FDAAA)

Bill Hubbard - For unparalleled commitment to and tireless efforts in support of the Food and Drug Administration's mission of promoting and protecting the public health of our nation (recipient nominated by FDAAA)

John Finlayson, Ph.D. - For 51 years of distinguished service to the cause of public health, through research, regulation, and inspired mentoring of the current generation of CBER scientist-regulators.

2009

Robert L. Lake - For distinguished service in improving the safety of the world's food supply and for exemplifying the spirit of service represented by FDA Alumni (recipient nominated by FDAAA)

Daniel L. Michels - For an exceptional life dedicated to protection of the public health and exemplary leadership that has enabled the FDA to fulfill its consumer protection mission (recipient nominated by FDAAA)

2008

Elizabeth D. Krell, Ph.D. - For exceptional scientific leadership of FDA programs, international harmonization, consensus standards, device trade association programs, and alumni relations that contribute to the public health. (recipient nominated by FDAAA)

Arthur Norris - For vision, dedication and commitment to advancing FDA science, education and public health goals.

Linda A. Suydam, D.P.A. - For exceptional management of FDA programs in medical devices, radiological health, and agency-wide, and leadership to fight abuse and insure safe use of over-the-counter medicines. (recipient nominated by FDAAA)

2007

Michael J. Blackwell, D.V.M. – For continuing meaningful support of the FDA mission following his retirement that fully reflects his dedication to the Agency and to protecting the public health.

Robert W. Sauer – For extraordinary service to FDA that continues following retirement and is fully reflective of his strong commitment to government service and protection of public health.

2006

F. Alan Andersen, Ph.D. – For exceptional contributions to FDA and public health as a senior scientist and program manager in radiological health, medical devices, cosmetic safety and alumni relations. (recipient nominated by FDAAA)

W. Fred Hooten – For many years of outstanding leadership, commitment and foresight, resulting in significant changes in the regulation of the medical device industry which had a profound impact on manufacturing standards in the U.S. and the global arena through improvement of FDA programs that focus on the importance of Quality Systems in the protection of public health.

2005

Douglas Archer, Ph.D. – For continued outstanding contributions to the Food and Drug Administration’s food safety programs and meeting the Agency’s mission of protecting the public health of the American people.

Anthony C. Celeste – For sustained, high quality managerial and technical leadership within and outside FDA and continued dedication to protecting public health by upholding FDA’s mission and values. (recipient nominated by FDAAA)

Peter Barton Hutt, Esq. – For contributions to food and drug law and policy, and for providing leadership to the FDA bar for many decades. (recipient nominated by FDAAA)

2004

Sherwin Gardner – For enlightened, steady and dedicated leadership of the Food and Drug Administration during critical turning points in the Agency’s history. (recipient nominated by FDAAA)

Richard A. Merrill, Esq. – For furthering the scholarship of food and drug law as an author, teacher and government committee member and enhancing public understanding of FDA’s regulatory process. (recipient nominated by FDAAA)

Wayne L. Pines – For continued outstanding contributions in advancing public health by educating the public and private enterprise on the policies of the Food and Drug Administration. (recipient nominated by FDAAA)

2003

James Benson – For exceptional problem-solving skills, management excellence and a robust passion for valued government service, trademark qualities that have made him a highly effective public health leader within and outside the FDA. (recipient nominated by FDAAA)

J. Richard Crout, M.D. – For enlightened and committed leadership in bringing FDA’s drug review and regulatory programs to a position of world acclaim and respect during a time of unparalleled advancement in medical technologies. (recipient nominated by FDAAA)

2002

Jerome A. Halperin – For continued outstanding contributions to public health in the United States through service in the Commissioned Corps, Food and Drug Administration, United States Pharmacopeia and the Food and Drug Law Institute.

Michael R. Taylor, J.D. – For outstanding leadership, exemplary service, and exceptional dedication as Deputy Commissioner for Policy and in the area of food safety initiatives.

2001

Gerald L. Barkdoll, D.P.A. – For innovative leadership and exemplary service to FDA in establishing the Agency’s strategic management framework, and for outstanding contributions as a planning innovator in the public sector planning community.

Joseph P. Hile – For many years of exemplary senior executive leadership and outstanding contributions, and for being a lifelong trusted friend and colleague of the Food and Drug Administration.

John M. Taylor – For outstanding leadership in directing FDA’s nationwide enforcement and field operations and serving as a consummate public servant dedicated to the mission of consumer protection.

2000

Charles C. Edwards, M.D. – For a career of exceptional dedication and significant contributions to public health through service as Commissioner of FDA, leadership of a major medical research institution, and insightful leadership of the Advisory Committee on the FDA.

Sanford A. Miller, Ph.D. – For outstanding leadership, exceptional vision, and distinguished public service as Director of CFSAN and, subsequently, for continued substantial contributions to understanding food policy issues.

Mark Novitch, M.D. – For outstanding career achievements in public health and in recognition of your commitment to excellence when serving in, and recruiting for, leadership positions within the Office of the Commissioner at the FDA.

John C. Villforth – For superior leadership and a distinguished public health career dedicated to protecting American consumers by ensuring safe and effective medical devices and radiological health products.

1999

D. Bruce Burlington, M.D. – For exceptional vision, innovative leadership, and outstanding service to FDA while managing the regulation of biologics, human drugs, medical devices and radiation-emitting products.

Ronald G. Chesemore – For exceptional vision, competence, and dedication in directing nationwide enforcement and field operations of FDA, and for design and implementation of the Office of Criminal Investigations and the consolidation of FDA field laboratories.

Richard E. Geyer, J.D. – For sustained and distinguished service to FDA while serving as Deputy Director, Office of Surveillance and Compliance, Center for Veterinary Medicine from 1992 to 1999.

Gerald B. Guest, D.V.M. – For exemplary service and outstanding leadership when serving as the Director, Center for Veterinary Medicine, FDA, from 1986 to 1993.

M. Carolyn Hardegree, M.D. – For outstanding contributions to the Agency’s public health mission by oversight of the development, licensing, and use of safe and effective childhood vaccines.

Burton I. Love – For being an innovative leader, role model, and mentor to many other Agency leaders and serving as a consummate public servant dedicated to the mission of the Food and Drug Administration.

Arthur R. Norris – For 29 years of continued outstanding contributions, exceptional service, and managerial wisdom that had a major impact on the Food and Drug Administration and the achievement of its goals.

Carl C. Peck, M.D. – For continued outstanding efforts to improve the science of drug development in this country and abroad, as a friend and colleague of the FDA, as Director of Georgetown University’s Center for Drug Development Science, and as president of the American Society for Clinical Pharmacology and Therapeutics.

John H. Turner – For outstanding leadership, commitment to excellence, and the highest professional standards applied to technical and managerial leadership of the Southeast Region of the Food and Drug Administration.

John E. Vanderveen, Ph.D. – For 37 years of distinctive Federal service of which 23 years were dedicated to work in FDA managing initiatives to promote and protect the public’s health by ensuring that the food supply was safe and food products were labeled honestly and accurately.